New York, May 26, 2010 – Heartbeat Experts, the leading provider of KOL management and Market Access solutions for the life sciences industry, today reported 70% year-to-date growth across all offerings. Strong growth was reported from each of Heartbeat Expert’s 10 worldwide offices and across all offerings of consulting, data and software.
In support of these growth numbers, Heartbeat Experts has opened new offices in Singapore, Madrid and Milan, and growing sales and implementation teams based in these new and existing offices.
“Sales in emerging markets and Asia is an important factor in our steady growth numbers,” said Jonah Meyers, CEO of Heartbeat Experts. “Our offering continues to distinguish itself in the market, combining software, data and consulting. Expanding offices worldwide allows this unique offering to reach our growing global client base.”
Larry Cohen, Heartbeat’s President, added, “The 70% growth spanned all aspects of our business, from medical and market access strategy, strategic data analytics, and software for stakeholder and KOL management. With over 100 existing clients worldwide, year over year, we’ve been able to offer new solutions that support our client’s entire product lifecycle, and that’s driving our growth.”
Koen Janssens, Executive Vice President, said, “With offices in Europe, the US and Asia, our local expertise ensures strong relationships and ongoing business with our clients. I am pleased we can continue to hire in support of this strong growth and provide the highest-quality service in local languages with local domain knowledge.”
Heartbeat Experts works with over 100 clients on key opinion leader management and pricing, reimbursement and market access projects from 10 offices worldwide. Offering a solution toolset comprised of software, data and strategic consulting, Heartbeat works with clinical, market access, policy and government affairs teams across the life sciences industry on KOL identification, stakeholder mapping, segmentation, and strategy for engagements with external stakeholders.
In today’s healthcare environment, life sciences companies face pricing, reimbursement, policy and regulatory challenges. In meeting these challenges…
A leading pharmaceutical enterprise was conducting several clinical trials in various stages on a compound, and realized…
© 2011 Heartbeat Experts. All rights reserved